Switch theme
Sign up to access all valuation multiples
Ubcare Co Ltd is a South Korea based company engages in the provision of healthcare solutions. It provides medical equipment, e-commerce services, and health functional foods online and offline, e-healthcare, mobile healthcare, home healthcare, and other healthcare services.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ubcare has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Ubcare achieved revenue of $130M and an EBITDA of $6.9M.
Ubcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ubcare valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $105M | $130M | XXX | XXX | XXX |
| Gross Profit | $46.2M | $55.1M | XXX | XXX | XXX |
| Gross Margin | 44% | 42% | XXX | XXX | XXX |
| EBITDA | $5.5M | $6.9M | XXX | XXX | XXX |
| EBITDA Margin | 5% | 5% | XXX | XXX | XXX |
| Net Profit | $2.4M | -$1.2M | XXX | XXX | XXX |
| Net Margin | 2% | -1% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Ubcare's stock price is KRW 3360 (or $2).
Ubcare has current market cap of KRW 170B (or $116M), and EV of KRW 164B (or $111M).
See Ubcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $111M | $116M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Ubcare has market cap of $116M and EV of $111M.
Ubcare's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Ubcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Ubcare and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $111M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 16.2x | XXX | XXX | XXX |
| P/E | -107.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -41.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpUbcare's NTM/LTM revenue growth is n/a
Ubcare's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Ubcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Ubcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Ubcare and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 25% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 47% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ubcare acquired XXX companies to date.
Last acquisition by Ubcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Ubcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Ubcare founded? | Ubcare was founded in 1992. |
| Where is Ubcare headquartered? | Ubcare is headquartered in South Korea. |
| Is Ubcare publicy listed? | Yes, Ubcare is a public company listed on KRX. |
| What is the stock symbol of Ubcare? | Ubcare trades under 032620 ticker. |
| When did Ubcare go public? | Ubcare went public in 1997. |
| Who are competitors of Ubcare? | Similar companies to Ubcare include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Ubcare? | Ubcare's current market cap is $116M |
| What is the current revenue growth of Ubcare? | Ubcare revenue growth between 2023 and 2024 was 24%. |
| Is Ubcare profitable? | Yes, Ubcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
